{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:05:32Z","timestamp":1790226332664,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Peripheral neuropathy (PN) is a neurological complication of untreated Human Immunodeficiency Virus (HIV) infection or exposure to certain antiretroviral drugs. In Tanzania where HIV is a major public health problem, the burden of HIV associated peripheral neuropathy has not yet been well defined in children.Thisstudy investigated the prevalence and associated factors for peripheral neuropathy among children living with HIV, attending Care and Treatment Clinic (CTC) at Muhimbili National Hospital (MNH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted among 383 HIV positive children aged 5 to 18 years at MNH, CTC in Dar es Salaam between October to December 2019. All participants provided written assent\/consent. Structured questionnaires designed for this study was used to collect data and screening for peripheral neuropathy was done on each participant using the Pediatric modified Total Neuropathy Score (Ped m TNS) that includes subjective and objective assessment. A score of 5 or greater on the Ped m TNS was used to define peripheral neuropathy. Data analysis was done using SPSS Version 23.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of peripheral neuropathy among HIV infected children was 14.1\u2009% (95\u2009% CI (10.8 \u2212\u200918\u2009%). Common neuropathic symptoms were numbness, tingling sensation, reduced ankle reflexes and reduced sensation to light touch and pain that was limited to the toes. Low CD4 cell count (OR\u2009=\u200912.21; 95\u2009% CI3.75\u201339.66;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001), high viral load (OR\u2009=\u200910.54; 95\u2009% CI 3.19\u201334.77;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001), ART regime containing NRTI plus PI (OR\u2009=\u20093.93; 95\u2009% CI 1.43\u2013 10.74;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01) and the last exposure to isoniazid more than 6 months ago (OR\u2009=\u20093.71; 95\u2009% CI 1.57\u20138.77;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) were independent predictors for peripheral neuropathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Peripheral neuropathy is common among HIV infected children attending CTC at MNH and its frequency increases with advanced disease. The choice of ART regimen and other drugs for treating comorbid conditions should carefully be evaluated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02335-0","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T04:03:45Z","timestamp":1628827425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Peripheral neuropathy in HIV-infected children attending care and treatment clinic, at Muhimbili National Hospital, Dar es Salaam: a cross sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Insiyah A","family":"Amiji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga E","family":"Naburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livin P","family":"Mumburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"issue":"5","key":"2335_CR1","first-page":"243","volume":"2013","author":"SG Sch\u00fctz","year":"2013","unstructured":"Sch\u00fctz SG, Robinson-Papp J. HIV-related neuropathy: current perspectives. HIV\/AIDS - Res Palliat Care. 2013;2013(5):243\u201351.","journal-title":"HIV\/AIDS - Res Palliat Care"},{"issue":"11","key":"2335_CR2","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/0883073811405203","volume":"26","author":"R Govender","year":"2011","unstructured":"Govender R, Eley B, Walker K, Petersen R, Wilmshurst JM. Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection. J Child Neurol. 2011;26(11):1355\u201364.","journal-title":"J Child Neurol"},{"key":"2335_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/AJP.0000000000000476","volume":"33","author":"KJ Morgan","year":"2017","unstructured":"Morgan KJ, Anghelescu DL. A review of adult and pediatric neuropathic pain assessment tools. Clin J Pain. 2017;33:844\u201352.","journal-title":"Clin J Pain"},{"issue":"1","key":"2335_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/archneur.56.1.84","volume":"56","author":"M Tagliati","year":"1999","unstructured":"Tagliati M, Grinnell J, Godbold J, Simpson DM. Peripheral Nerve Function in HIV Infection. Arch Neurol. 1999;56(1):84\u20139.","journal-title":"Arch Neurol"},{"issue":"11","key":"2335_CR5","first-page":"1778","volume":"65","author":"CL Cherry","year":"2005","unstructured":"Cherry CL, Wesselingh SL LL. Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Am Acad Nerology. 2005;65(11):1778\u201381.","journal-title":"Am Acad Nerology"},{"key":"2335_CR6","unstructured":"Ministry of Health, Community Development, Gender E and C. National Guidelines For the Management of HIV and AIDS. 2019."},{"issue":"3","key":"2335_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00520-012-1591-8","volume":"21","author":"LS Gilchrist","year":"2013","unstructured":"Gilchrist LS, Tanner L. The pediatric-modified total neuropathy score: A reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer. 2013;21(3):847\u201356.","journal-title":"Support Care Cancer"},{"issue":"3","key":"2335_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/01893697-200927030-00002","volume":"27","author":"LS Gilchrist","year":"2009","unstructured":"Gilchrist LS, Tanner L HC. Measuring chemotherapy-induced peripheral neuropathy in children: development of the Ped-mTNS and pilot study results. Rehabil Oncol. 2009;27(3):7\u201315.","journal-title":"Rehabil Oncol"},{"issue":"4","key":"2335_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1043454218762705","volume":"35","author":"S Smolik","year":"2018","unstructured":"Smolik S, Arland L, Hensley MA, Schissel D, Shepperd B, Thomas K, et al. Assessment Tools for Peripheral Neuropathy in Pediatric Oncology: A Systematic Review From the Children\u2019s Oncology Group. J Pediatr Oncol Nurs. 2018;35(4):267\u201375.","journal-title":"J Pediatr Oncol Nurs"},{"issue":"1","key":"2335_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1212\/WNL.49.1.207","volume":"49","author":"MK Floeter","year":"1997","unstructured":"Floeter MK, Civitello LA, Everett CR et al. Peripheral neuropathy in children with HIV infection. Neurology. 1997;49(1):207\u201312.","journal-title":"Neurology"},{"issue":"4","key":"2335_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jpainsymman.2010.07.006","volume":"41","author":"AL Wadley","year":"2011","unstructured":"Wadley AL, Cherry CL, Price P et al. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manage. 2011;41(4):700\u20136.","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"2335_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1468-1293.2007.00478.x","volume":"8","author":"K Smyth","year":"2007","unstructured":"Smyth K, Affandi JS, Mcarthur JC, Bowtell-harris C, Mijch AM, Watson K, et al. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993\u20132006. HIV Med. 2007;8(6):367\u201373.","journal-title":"HIV Med"},{"issue":"3","key":"2335_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.26719\/2012.18.3.298","volume":"18","author":"A Zaoui","year":"2012","unstructured":"Zaoui A, Abdelghani A, Salem H Ben, Ouanes W, Hayouni A, Khachnaoui F, et al. Early-onset severe isoniazid-induced motor- dominant neuropathy: a case report. East Mediterr Heal J. 2012;18(3):298\u20139.","journal-title":"East Mediterr Heal J"},{"issue":"5","key":"2335_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/QAI.0b013e3181bb268d","volume":"52","author":"PM Esteban","year":"2012","unstructured":"Esteban PM, Thahn TG, Bravo JF, Roca LK, Quispe NM, Montano SM JZ. Malnutrition Associated With Increased Risk of Peripheral Neuropathy in Peruvian Children With HIV Infection. J Acquir Immune Defic Syndr. 2012;52(5):656\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"2335_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1258\/095646206777689062","volume":"17","author":"EE Skopelitis","year":"2006","unstructured":"Skopelitis EE, Kokotis PI, Kontos AN, Panayiotakopoulos GD, Konstantinou K, Kordossis T, et al. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: An entity underestimated by clinical examination. Int J STD AIDS. 2006;17(7):467\u201372.","journal-title":"Int J STD AIDS"},{"key":"2335_CR16","unstructured":"Rusibamayila NJ. Neurological manifestation among children infected with human immunodeficiency virus\/acquired immunodefiency syndrome and associated factors. Tanzania: Muhimbili University of Health and Allied Sciences; 2002."},{"key":"2335_CR17","unstructured":"Alexandra Prufer de Q. C. Arau\u00b4 jo, Osvaldo J. M. Nascimento OSG. Distal Sensory Polyneuropathy in a Cohort of HIV-Infected Children Over Five Years of Age Alexandra. Am Acad Pediatr. 2000;106(3):316\u201320."},{"issue":"9","key":"2335_CR18","first-page":"1245","volume":"173","author":"RPH Peters","year":"2014","unstructured":"Peters RPH, Van Ramshorst MS, Struthers HE, McIntyre JA. Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa. Eur J Pediatr. 2014;173(9):1245\u20138.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"2335_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1212\/WNL.0000000000004136","volume":"89","author":"D Saylor","year":"2017","unstructured":"Saylor D, Nakigozi G, Nakasujja N, Kevin Robertson, Ronald H. Gray, Maria J. Wawer NS. Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda. Neurology. 2017;89(5):485\u201391.","journal-title":"Neurology"},{"issue":"1","key":"2335_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S1055-3290(06)60419-6","volume":"11","author":"CA Balt","year":"2000","unstructured":"Balt CA. An investigation of the relationship between vitamin B12 deficiency and HIV infection. J Assoc Nurses AIDS Care. 2000;11(1):24\u201335.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"3","key":"2335_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1212\/WNL.52.3.607","volume":"52","author":"E Childs","year":"1999","unstructured":"Childs E, Lyles R, Selnes O, Chen B, Miller E, Cohen B, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52(3):607.","journal-title":"Neurology"},{"issue":"9","key":"2335_CR22","first-page":"945","volume":"45","author":"T Yuen","year":"2015","unstructured":"Yuen T. So, David M. Holtzman,; Donald I. Abrams RKO. Peripheral Neuropathy Associated With Acquired Immunodeficiency Syndrome Population-Based Survey. Arch Neurol. 2015;45(9):945\u20138.","journal-title":"Arch Neurol"},{"key":"2335_CR23","unstructured":"Phasing out Stavudine: Progress and Challenges. 2013. Available from: https:\/\/www.who.int\/hiv."},{"key":"2335_CR24","first-page":"1","volume":"9047","author":"NS Shetty","year":"2018","unstructured":"Shetty NS, Shah I. Paediatrics and International Child Health Isoniazid-induced neuropathy in a pre-pubertal child. Paediatr Int Child Health. 2018;9047:1\u20133.","journal-title":"Paediatr Int Child Health"},{"key":"2335_CR25","unstructured":"World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children.\u00a02019;69. Available from: https:\/\/www.who.int\/tb."},{"issue":"5","key":"2335_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.21484","volume":"64","author":"R Ellis","year":"2009","unstructured":"Ellis R, Debralee Rosario, David B. Clifford, Justin C. McArthur DS, Marquie-beck J, Delaney P, Clifford DB, Mcarthur JC, David M et al. HIV Protease Inhibitors and Risk of Peripheral Neuropathy Ronald. Ann Neurol. 2009;64(5):566\u201372.","journal-title":"Ann Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02335-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T04:04:31Z","timestamp":1628827471000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02335-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2335"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02335-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-149035\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"assertion":[{"value":"16 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}